Blue Trust Inc. Has $11.08 Million Stock Position in HCA Healthcare, Inc. $HCA

Blue Trust Inc. lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 10.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,721 shares of the company’s stock after selling 2,663 shares during the quarter. Blue Trust Inc.’s holdings in HCA Healthcare were worth $11,075,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Linden Thomas Advisory Services LLC increased its holdings in HCA Healthcare by 4.7% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 652 shares of the company’s stock worth $304,000 after purchasing an additional 29 shares in the last quarter. RHS Financial LLC grew its holdings in shares of HCA Healthcare by 54.9% during the fourth quarter. RHS Financial LLC now owns 1,507 shares of the company’s stock worth $704,000 after buying an additional 534 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in HCA Healthcare by 31.3% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 1,070 shares of the company’s stock valued at $500,000 after acquiring an additional 255 shares in the last quarter. Frank Rimerman Advisors LLC grew its stake in shares of HCA Healthcare by 0.6% during the 4th quarter. Frank Rimerman Advisors LLC now owns 6,801 shares of the company’s stock worth $3,175,000 after acquiring an additional 39 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its position in shares of HCA Healthcare by 20.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 70,580 shares of the company’s stock worth $32,951,000 after purchasing an additional 12,126 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,214 shares of company stock valued at $7,797,595 in the last three months. 1.50% of the stock is owned by insiders.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q4 earnings recap reinforces momentum — analysts and outlets are reflecting on HCA’s recent Q4 results (EPS beat and raised FY guidance), which underpin investor confidence in earnings power and the company’s outlook. Reflecting On Hospital Chains Stocks’ Q4 Earnings: HCA Healthcare
• Positive Sentiment: Corporate philanthropy and community engagement — HCA kicked off a month of volunteerism and, through the HCA Healthcare Foundation, committed $2 million to Second Harvest Food Bank of Middle Tennessee, supporting local goodwill and community relations. HCA Healthcare Kicks off Month of Volunteerism and Announces $2 Million Grant HCA Healthcare Foundation names new leader, gives $2 million
• Neutral Sentiment: Leadership changes at regional hospitals — HCA named new CEOs at an HCA Florida hospital and an HCA Tennessee hospital; routine executive appointments that support local continuity but are unlikely to move fundamentals materially. HCA Florida hospital names CEO
• Neutral Sentiment: Additional local leadership update — separate Beckers item on an HCA Tennessee hospital CEO naming; operational governance note for regional investors. HCA Tennessee hospital names CEO
• Neutral Sentiment: Community grants and EMS coverage stories — local grant news (TriStar $40K) and AirLife coverage highlight community/operational activity within HCA’s ecosystem; good for reputation but minor for near‑term financials. TriStar announces $40,000 grant AirLife takes flight
• Negative Sentiment: Potential regulatory risk at a local hospital — Rep. Edwards proposed giving CMS authority to “take over” Mission Hospital, a development that could signal heightened regulatory scrutiny or intervention risk in markets where HCA operates; investors should monitor for whether this targets an HCA facility or broader policy shifts. Rep. Edwards wants to give CMS ability to ‘take over’ Mission Hospital

HCA Healthcare Stock Performance

Shares of HCA stock opened at $475.49 on Thursday. The company has a market capitalization of $106.30 billion, a price-to-earnings ratio of 16.75, a PEG ratio of 1.45 and a beta of 1.36. HCA Healthcare, Inc. has a 52 week low of $314.43 and a 52 week high of $556.52. The company has a 50-day simple moving average of $511.03 and a 200 day simple moving average of $477.46.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the business posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were given a $0.78 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HCA. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target on the stock. in a research note on Monday, December 15th. Argus lifted their target price on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Deutsche Bank Aktiengesellschaft raised their price target on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Royal Bank Of Canada upped their price objective on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Finally, Truist Financial boosted their target price on shares of HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.